Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.
O'Brien S, Rizzieri DA, Vey N, Ravandi F, Krug UO, Sekeres MA, Dennis M, Venditti A, Berry DA, Jacobsen TF, Staudacher K, Bergeland T, Giles FJ.
O'Brien S, et al. Among authors: bergeland t.
Br J Haematol. 2012 Sep;158(5):581-8. doi: 10.1111/j.1365-2141.2012.09186.x. Epub 2012 Jun 15.
Br J Haematol. 2012.
PMID: 22702906
Free PMC article.
Clinical Trial.